Yoland Antill

Associate Professor Yoland Antill is an Adjunct Associate Professor at Monash University and a Medical Oncologist at Cabrini, Peninsula, and Melbourne Health Services in Australia. With over 20 years of experience in Medical Oncology and Cancer Genetics, her research focuses on breast and gynaecological cancers, hereditary cancer syndromes, and clinical trial development. She leads multiple international studies, including the OPTIMA and CAMBRIA-1 trials, and chairs ANZGOG's Uterine Tumour Working Group. Her advisory roles include Breast Cancer Network Australia and Ovarian Cancer Australia. She holds a BMed, FRACP, and MD.

• Education: Bachelor of Medicine (BMed), Fellowship of the Royal Australasian College of Physicians (FRACP), Medical Doctorate (MD)
• Key Roles: Medical Oncologist, Cancer Genetics specialist, Chair of ANZGOG Uterine Tumour Group, Industry advisory boards

Research Interests

Dr. Antill’s work emphasizes translational research in breast and gynaecological cancers, hereditary syndromes, and supportive care. Her studies explore novel therapies, genomic biomarkers, and improving patient outcomes through clinical trials. She has published extensively on topics like contralateral breast cancer risk, germline variants, and endometrial cancer staging.

Projects & Trials

• Optimal Personalised Treatment of early breast cancer (OPTIMA) – Multi-parameter analysis for treatment optimization
• CAMBRIA-1 – Phase III trial of Camizestrant for ER+/HER2- early breast cancer
• VERITAC-3 – ARV-471 in advanced breast cancer

Awards & Recognition

No specific scientific awards listed, though her extensive clinical and research contributions are highlighted in peer-reviewed publications and industry collaborations.